97 results
8-K
EX-4.1
PHIO
Phio Pharmaceuticals Corp
8 Dec 23
Phio Pharmaceuticals Announces Exercise of Warrants
5:00pm
to the Black Scholes Value (as defined below) of the remaining unexercised portion of this Warrant on the date of the consummation of such Fundamental … ), at the Black Scholes Value (as defined below) of the unexercised portion of this Warrant, that is being offered and paid to the holders of Common
8-K
EX-4.2
PHIO
Phio Pharmaceuticals Corp
8 Dec 23
Phio Pharmaceuticals Announces Exercise of Warrants
5:00pm
by paying to the Holder an amount of cash equal to the Black Scholes Value (as defined below) of the remaining unexercised portion of this Warrant … type or form of consideration (and in the same proportion), at the Black Scholes Value (as defined below) of the unexercised portion of this Warrant
8-K
EX-4.2
u9k8 apw7
2 Jun 23
Phio Pharmaceuticals Announces $4 Million Concurrent Registered Direct
4:30pm
8-K
EX-4.1
myebdbz9 i1gzaau
2 Jun 23
Phio Pharmaceuticals Announces $4 Million Concurrent Registered Direct
4:30pm
8-K
r50etw8
2 Jun 23
Phio Pharmaceuticals Announces $4 Million Concurrent Registered Direct
4:30pm
424B5
fezi9r8r4e0nh54jc
1 Jun 23
Prospectus supplement for primary offering
5:00pm
8-K
EX-4.1
rllj4 qs8ory
20 Apr 23
Phio Pharmaceuticals Announces $2 Million Registered Direct
2:53pm
8-K
u62qtfr18mwdx4lh
20 Apr 23
Phio Pharmaceuticals Announces $2 Million Registered Direct
2:53pm
8-K
EX-4.2
fnx5nqir99snnlhbeb
20 Apr 23
Phio Pharmaceuticals Announces $2 Million Registered Direct
2:53pm
424B5
ztj xdca5p9xb
19 Apr 23
Prospectus supplement for primary offering
5:06pm